glp-1 news today october 23 2025 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Pipeline Update: May 2025

J Clin Epidemiol

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice

The specific codes applied from the various classification systems are detailed in the Supplementary Data (Appendix 1 in S1 File)

These medications are part of a growing category of treatments that may help support weight loss when used alongside lifestyle changes and medical supervision

Eli Lilly's Foundayo, a daily weight-loss pill, as well as Zepbound KwikPen, a weekly weight-loss injection, are covered, along with Novo Nordisk's Wegovy weight-loss medication in both injection and pill forms

A proposed mechanism involves a specific secreted protein from A